Ceftolozane/Tazobactam: Outpatient Treatment of Gram-Negative Infections at Physician Office Infusion Centers (POICs)

Ramesh V. Nathan; Fernando S. Alvarado; Richard C. Prokesch; Quyen Luu; Thomas K. Sleweon; Claudia P. Schroeder; Lucinda J. Van Anglen

doi:10.1093/OFID/OFW172.1603

Ceftolozane/Tazobactam: Outpatient Treatment of Gram-Negative Infections at Physician Office Infusion Centers (POICs)

Ramesh V. Nathan
, Fernando S. Alvarado
, Richard C. Prokesch
, Quyen Luu
, Thomas K. Sleweon
, Claudia P. Schroeder
, Lucinda J. Van Anglen

Mazur, Statner, Dutta, Nathan, PC, Thousand Oaks, California
Infectious Disease Consultants, MD, PA, Altamonte Springs, Florida
Infectious Diseases Associates, Riverdale, Georgia
Quyen Luu, MD, Macon, Georgia
ID Specialists of Indiana, Highland, Indiana
Healix Infusion Therapy, Inc., Sugar Land, Texas

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Open Forum Infectious Diseases
Volume	3
DOIs	https://doi.org/10.1093/OFID/OFW172.1603
State	Published - Dec 1 2016
Externally published	Yes

Disciplines

Medicine and Health Sciences
Critical Care

Access to Document

10.1093/OFID/OFW172.1603License: Unspecified

Cite this

@article{af9636a990844019a7f26d9583af1368,

title = "Ceftolozane/Tazobactam: Outpatient Treatment of Gram-Negative Infections at Physician Office Infusion Centers (POICs)",

author = "Nathan, \{Ramesh V.\} and Alvarado, \{Fernando S.\} and Prokesch, \{Richard C.\} and Quyen Luu and Sleweon, \{Thomas K.\} and Schroeder, \{Claudia P.\} and \{Van Anglen\}, \{Lucinda J.\}",

note = "Background. Ceftolozane/tazobactam (C/T) is a novel cephalosporin and beta-lactamase inhibitor combination with enhanced activity against multidrug-resistant (M",

year = "2016",

month = dec,

day = "1",

doi = "10.1093/OFID/OFW172.1603",

language = "American English",

volume = "3",

journal = "Open Forum Infectious Diseases",

}

TY - JOUR

T1 - Ceftolozane/Tazobactam: Outpatient Treatment of Gram-Negative Infections at Physician Office Infusion Centers (POICs)

AU - Nathan, Ramesh V.

AU - Alvarado, Fernando S.

AU - Prokesch, Richard C.

AU - Luu, Quyen

AU - Sleweon, Thomas K.

AU - Schroeder, Claudia P.

AU - Van Anglen, Lucinda J.

N1 - Background. Ceftolozane/tazobactam (C/T) is a novel cephalosporin and beta-lactamase inhibitor combination with enhanced activity against multidrug-resistant (M

PY - 2016/12/1

Y1 - 2016/12/1

UR - https://academic.oup.com/ofid/article/3/suppl_1/2055/2636332

U2 - 10.1093/OFID/OFW172.1603

DO - 10.1093/OFID/OFW172.1603

M3 - Article

VL - 3

JO - Open Forum Infectious Diseases

JF - Open Forum Infectious Diseases

ER -

Ceftolozane/Tazobactam: Outpatient Treatment of Gram-Negative Infections at Physician Office Infusion Centers (POICs)

Disciplines

Access to Document

Other files and links

Cite this